Omar Farouque

Prof. Dr. Omar Farouque


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2020 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
Carol Y. L. CheungCarol Y. L. Cheung
Carol Y. L. Cheung
DXDejiang Xu
Dejiang Xu
CCChing-Yu Cheng
Ching-Yu Cheng
CSCharumathi Sabanayagam
Charumathi Sabanayagam
YTYih-Chung Tham
Yih-Chung Tham
TWTien Yin Wong
Tien Yin Wong

4 August 2020 in Cardiovascular Research
Verified
Journal Article
Closed access
JTJames Theuerle
James Theuerle
AAAli Al-Fiadh
Ali Al-Fiadh
FIFakir M Amirul Islam
Fakir M Amirul Islam
SPSheila Patel
Sheila Patel
LBLouise M Burrell
Louise M Burrell
OFOmar Farouque
Omar Farouque
Aims: Endothelial dysfunction is a precursor to the development of symptomatic atherosclerosis. Retinal microvascular reactivity to flicker light stimulation is a marker of endothelial function and can be quantified in vivo. We sought to determine whether retinal microvascular endothelial dysfunction predicts long-term major adverse cardiovascular events (MACE). Methods and results: In a single-centre prospective observational study, patients with coronary artery disease (CAD) or cardiovascular risk factors underwent dynamic retinal vessel assessment in response to flicker light stimulation and were followed up for MACE. Retinal microvascular endothelial dysfunction was quantified by measuring maximum flicker light-induced retinal arteriolar dilatation (FI-RAD) and flicker light-induced retinal venular dilatation (FI-RVD). In total, 252 patients underwent dynamic retinal vessel assessment and 242 (96%) had long-term follow-up. Of the 242 patients, 88 (36%) developed MACE over a median period of 8.6 years (interquartile range 6.0–9.1). After adjustment for traditional risk factors, patients within the lowest quintile of FI-RAD had the highest risk of MACE [odds ratio (OR) 5.21; 95% confidence interval (CI) 1.78–15.28]. Patients with lower FI-RAD were also more likely to die (OR 2.09; 95% CI 1.00–4.40, per standard deviation decrease in FI-RAD). In Kaplan–Meier analysis, patients with FI-RAD responses below the cohort median of 1.4% exhibited reduced MACE-free survival (55.5 vs. 71.5%; log-rank P = 0.004). FI-RVD was not predictive of MACE. Conclusion: Retinal arteriolar endothelial dysfunction is an independent predictor of MACE in patients with CAD or cardiovascular risk factors. Dynamic retinal vessel analysis may provide added benefit to traditional risk factors in stratifying patients at risk for cardiovascular events.

1 March 2015 in The American Journal of Cardiology
Verified
Journal Article
Closed access
AAAli Al-Fiadh
Ali Al-Fiadh
TWTien Y. Wong
Tien Y. Wong
RKRyo Kawasaki
Ryo Kawasaki
DCDavid J. Clark
David J. Clark
SPSheila Patel
Sheila Patel
OFOmar Farouque
Omar Farouque

1 April 2014 in Atherosclerosis
Verified
Journal Article
Closed access
AAAli H. Al-Fiadh
Ali H. Al-Fiadh
OFOmar Farouque
Omar Farouque
RKRyo Kawasaki
Ryo Kawasaki
TNT.T. Nguyen
T.T. Nguyen
NUNazim Uddin
Nazim Uddin
TWTien Y. Wong
Tien Y. Wong

Verified
Journal Article
Open access
PDF file
ANAhthavan Narendren
Ahthavan Narendren
NWNatalie Whitehead
Natalie Whitehead
LBLouise M Burrell
Louise M Burrell
MYMatias B. Yudi
Matias B. Yudi
JYJulian Yeoh
Julian Yeoh
AKAnoop N. Koshy
Anoop N. Koshy
Managing health care for older adults aged 75 years and older can pose unique challenges stemming from age-related physiological differences and comorbidities, along with elevated risk of delirium, frailty, disability, and polypharmacy. This review is aimed at providing a comprehensive analysis of the management of acute coronary syndromes (ACS) in older patients, a demographic substantially underrepresented in major clinical trials. Because older patients often exhibit atypical ACS symptoms, a nuanced diagnostic and risk stratification approach is necessary. We aim to address diagnostic challenges for older populations and highlight the diminished sensitivity of traditional symptoms with age, and the importance of biomarkers and imaging techniques tailored for older patients. Additionally, we review the efficacy and safety of pharmacological agents for ACS management in older people, emphasizing the need for a personalized and shared decision-making approach to treatment. This review also explores revascularization strategies, considering the implications of invasive procedures in older people, and weighing the potential benefits against the heightened procedural risks, particularly with surgical revascularization techniques. We explore the perioperative management of older patients experiencing myocardial infarction in the setting of noncardiac surgeries, including preoperative risk stratification and postoperative care considerations. Furthermore, we highlight the critical role of a multidisciplinary approach involving cardiologists, geriatricians, general and internal medicine physicians, primary care physicians, and allied health, to ensure a holistic care pathway in this patient cohort.

1 September 2019 in International Journal of Cardiology
Verified
Journal Article
Closed access
JTJames Theuerle
James Theuerle
OFOmar Farouque
Omar Farouque
SVSheran Vasanthakumar
Sheran Vasanthakumar
SPSheila K. Patel
Sheila K. Patel
LBLouise M. Burrell
Louise M. Burrell
AAAli H. Al-Fiadh
Ali H. Al-Fiadh